| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 465521-19-1 | (3-Furylethynyl)(Trimethyl)Silane | C9H12OSi |
| 465527-59-7 | Trihexyl(Tetradecyl)Phosphonium Bis(2,4,4-Trimethylpentyl)Phosphinate | C48H102O2P2 |
| 465527-65-5 | Trihexyl(Tetradecyl)Phosphonium Decanoate | C42H87O2P |
| 465529-56-0 | 5-Bromo-2-methyl-2H-indazole | C8H7BrN2 |
| 465529-57-1 | 5-Bromo-1-methyl-1H-indazole | C8H7BrN2 |
| 465530-93-2 | N,N,3,5-Tetramethyl-1-Piperazinecarboxamide | C9H19N3O |
| 465536-44-1 | (4S,4aS,8aS)-4-Phenyldecahydro-4-Quinolinol | C15H21NO |
| 466639-53-2 | 3-Bromo-4-iodoanisole;2-Bromo-1-iodo-4-methoxybenzene | C7H6BrIO |
| 466678-44-4 | Lactosyl Pregabalin Pyrrolidone;(4S)-1-((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxyoxan-2-yl)-4-(2-methylpropyl)pyrrolidin-2-one | C20H35NO11 |
| 467214-20-6 / 150270-08-9 | Alvespimycin;17-Demethoxy-17-((2-(dimethylamino)ethyl)amino)geldanamycin; 17-DMAG | C32H48N4O8 |
| 467214-21-7 | Alvespimycin hydrochloride;17-DMAG hydrochloride; BMS 826476; KOS 1022; 17-Demethoxy-17-((2-(dimethylamino)ethyl)amino)geldanamycin hydrochloride | C32H48N4O8.HCl |
| 467214-46-6 | 6-Chloro-1H-indol-3-yl alpha-D-glucopyranoside | C14H16ClNO6 |
| 467220-49-1 | 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene (1,4-naphthoquinone)palladium dimer | C62H60N4O4Pd2 |
| 467223-90-1 | 3,5-Difluorobenzeneethanol | C8H8F2O |
| 467435-07-0 | 4-Bromo-2-chlorobenzotrifluoride | C7H3BrClF3 |
| 467435-58-1 | 32,35-Bis(2-((2,4-diethylheptyl)oxy)ethoxy)-6,7,9,10,12,13,15,16,18,19-decahydro-31H-4,21-(methano(1,3)benzenomethano)-26,30-metheno-25H-dibenzo(q,z)(1,4,7,10,13,16)hexaoxacycloheptacosin | C64H94O10 |
| 467442-12-2 | 3,5-Difluoro-4-formylbenzoic acid 1,1-dimethylethyl ester | C12H12F2O3 |
| 467442-15-5 | 4-Cyano-2,6-difluorobenzaldehyde;3,5-Difluoro-4-formylbenzonitrile | C8H3F2NO |
| 467442-20-2 | (S)-2-(tert-Butoxycarbonylamino)-4,4-difluorobutanoic acid | C9H15F2NO4 |
| 467451-91-8 | 6-Trifluoromethoxy-1H-indole | C9H6F3NO |
| 467458-02-2 | N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine monohydrochloride | C20H19F5N2O.HCl |
| 467458-46-4 | 3-Formyl-1H-indole-5-carboxylic acid ethyl ester;3-Formyl-5-ethoxycarbonyl-1H-indole | C12H11NO3 |
| 467459-31-0 | N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine;Lu AE 58054 | C20H19F5N2O |
| 467461-40-1 | 6-(Methylsulfonyl)-1H-Indole | C9H9NO2S |
| 468068-28-2 | 6-Amino-N-Hydroxy-3-Pyridinecarboximidamide | C6H8N4O |
| 468068-39-5 | 6-Chloro-N'-Hydroxy-3-Pyridinecarboximidamide | C6H6ClN3O |
| 468068-58-8 | 2-Chloro-N'-Hydroxy-3-Pyridinecarboximidamide | C6H6ClN3O |
| 468074-91-1 | 1-[2-Methoxy-5-(Trifluoromethoxy)Phenyl]Ethanol | C10H11F3O3 |
| 468074-92-2 | 1-[2-Methoxy-5-(Trifluoromethoxy)Phenyl]Ethanone | C10H9F3O3 |
| 468075-00-5 | 2-Bromo-1-chloro-4-(trifluoromethoxy)benzene | C7H3BrClF3O |
| 468095-63-8 | 2,3,4,6-Tetra-O-Benzyl-1-O-[(Z)-{[4-(Trifluoromethyl)Benzyl]Sulfanyl}{[4-(Trifluoromethyl)Phenyl]Imino}Methyl]-alpha-D-Glucopyranose | C50H45F6NO6S |
| 468718-16-3 | 5-(Trifluoromethyl)-1H-indole-3-carboxaldehyde | C10H6F3NO |
| 468718-30-1 | 5-Cyano-2-fluorophenylboronic acid;5-Cyano-2-fluorobenzeneboronic acid | C7H5BFNO2 |
| 468718-67-4 | 3-Chloro-N-Methyl-2-Pyridinamine | C6H7ClN2 |
| 468740-43-4 | BMS-536924;Insulin-like Growth Factor-1 Receptor Inhibitor; 4-(((2S)-2-(3-Chlorophenyl)-2-hydroxyethyl)amino)-3-(7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl)-2(1H)-pyridinone | C25H26ClN5O3 |
| 468741-20-0 | 2-Methyl-4-(4-Morpholinyl)-6-Nitro-Benzenamine | C11H15N3O3 |
| 468747-17-3 | mTOR inhibitor-1;3-bromo-N-(1-(2,4-dihydroxyphenyl)ethylideneamino)-4-methylbenzamide | C16H15BrN2O3 |
| 468751-38-4 | 2-(Phenylsulfonylmethyl)benzaldehyde | C14H12O3S |
| 468756-78-7 | 7-Chloro-2-ethyl-1H-indene | C11H11Cl |
| 469912-82-1 | 2,5-Bis(trimethylstannyl)thieno(3,2-b)thiophene | C12H20S2Sn2 |
| 470442-95-6 | 4-(1-Piperazinyl)-2-Pyridinamine | C9H14N4 |
| 470458-51-6 | 3,5-Difluoro-N-Methylaniline | C7H7F2N |
| 470463-34-4 | 2-(2,2-Dimethyl-Propionylamino)-Isonicotinic Acid | C11H14N2O3 |
| 470463-35-5 | 2-Chloro-3-[(Trimethylsilyl)Ethynyl]Pyridine | C10H12ClNSi |
| 470463-36-6 | N-(5-Iodo-Pyridin-2-Yl)-2,2-Dimethyl-Propionamide | C10H13IN2O |
| 470463-37-7 | 2-[(2,2-Dimethyl-1-Oxopropyl)Amino]-4-Pyridinecarboxamide | C11H15N3O2 |
| 470463-39-9 | 2-[(2,2-Dimethyl-1-Oxopropyl)Amino]-4-Pyridinecarboxylicacid Hydrazide | C11H16N4O2 |
| 470463-40-2 | 4-(3-Iodo-Pyridin-2-Yl)-Morpholine | C9H11IN2O |
| 470463-41-3 | 2-Methyl-2-Propanyl {5-[(Trimethylsilyl)Ethynyl]-2-Pyridinyl}Carbamate | C15H22N2O2Si |
| 470463-42-4 | 4-(5-Iodo-1H-Pyridin-2-Yl)Morpholine | C9H12IN2O |